Lv1
40 积分 2025-06-04 加入
ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients (pts) with P53 wild-type, advanced or recurrent endometrial carcinoma (1246)
1天前
求助中
POS1006 PROFILING B AND PLASMA CELLS IN KIDNEY BIOPSIES FROM ANCA-ASSOCIATED VASCULITIS PATIENTS WITH GLOMERULONEPHRITIS AT SINGLE-CELL RESOLUTION
2天前
已完结
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
2天前
已完结
Development and evaluation of a self-administered version of the ALSFRS-R
30天前
已完结
“Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial
1个月前
已完结
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)
1个月前
已完结
Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?
2个月前
已完结
What’s behind thoracic surgery explosion in young patients under the age of 40 in Wuhan after COVID-19 outbreak?
3个月前
已完结
The Rising Procedural Burden in Vascular Surgery: An 8-Year Nationwide Population-Based Analysis with Projections to 2035
3个月前
已关闭
Trends and Regional Disparities of Cardiothoracic Anesthesia Procedures in China Between 2016 and 2023
3个月前
已完结
皖公网安备34019202002308
